This is a news story, published by Sky News, that relates primarily to The Blood Biomarker Challenge news.
For more disease research news, you can click here:
more disease research newsFor more news from Sky News, you can click here:
more news from Sky NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
amyloid beta. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Amyloid protein news, dementia diagnosis news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
medical journal AlzheimerSky News
•Health
Health
87% Informative
Scientists looked for two proteins - amyloid beta 42/40 and p-tau217 - in blood plasma.
They found the test was 95% accurate in identifying patients with cognitive impairment linked to condition.
The test was also 82% accurate for specificity, meaning it could rule out people without dementia.
The Blood Biomarker Challenge is a multi-million pound research programme.
VR Score
93
Informative language
94
Neutral language
78
Article tone
formal
Language
English
Language complexity
51
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
2
Source diversity
2
Affiliate links
no affiliate links